» Articles » PMID: 27858246

Sequential Therapy Consisting of Glucocorticoid Infusions Followed by Granulocyte-monocyte Absorptive Apheresis in Patients with Severe Alcoholic Hepatitis

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 2016 Nov 19
PMID 27858246
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Activated leukocytes infiltrating the liver contribute to the provocation of alcoholic hepatitis. Glucocorticoid induces the demargination of leukocytes from the hepatic sinusoids, whereas granulocyte-monocyte absorptive apheresis (GMA) removes leukocytes from the circulation. Thus, the usefulness of a sequential therapy consisting of glucocorticoid infusions followed by GMA was evaluated in patients with severe alcoholic hepatitis.

Methods: Patients with severe alcoholic hepatitis received intravenous injections of methylprednisolone (1,000 mg/day) for 3 or 4 days, and then GMA was performed every day for 3 days. Responders were defined as those with attenuated serum C-reactive protein (CRP) levels during the GMA procedures.

Results: Ten consecutive patients were enrolled. At the baseline, the Japan alcoholic hepatitis scores were 9 in two patients and 10 or more in eight patients, and the Model for End-Stage Liver Disease scores ranged from 22 to 43. In all the patients, the peripheral neutrophil counts increased and the serum levels of CRP, aspartate aminotransferase, IL-6, IL-8, TNF-α, and intercellular adhesion molecule 1 decreased immediately after the glucocorticoid infusions. However, a rebound increase in the serum CRP levels was observed in all patients after discontinuation of glucocorticoid infusions, but the maximal values during the GMA procedures were lower than the baseline values. Six patients were rescued, whereas the remaining four patients died because of sepsis, pneumonia, pancreatitis, and renal failure.

Conclusions: Sequential therapy combining glucocorticoid infusion and GMA was useful for attenuating liver injuries in patients with severe alcoholic hepatitis by preventing rebound increases in inflammatory reactions after discontinuation of glucocorticoid infusions, except in patients with bacterial infections and/or multiple organ failure.

Citing Articles

Immune cells in alcohol-related liver disease.

Xu H, Wang H Liver Res. 2025; 6(1):1-9.

PMID: 39959807 PMC: 11791833. DOI: 10.1016/j.livres.2022.01.001.


Granulocyte-monocyte/macrophage apheresis for steroid-nonresponsive or steroid-intolerant severe alcohol-associated hepatitis: A pilot study.

Kasuga R, Chu P, Taniki N, Yoshida A, Morikawa R, Tabuchi T Hepatol Commun. 2024; 8(2).

PMID: 38285891 PMC: 10830070. DOI: 10.1097/HC9.0000000000000371.


Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases.

Ait Ahmed Y, Lafdil F, Tacke F Hepat Med. 2023; 15:113-127.

PMID: 37753346 PMC: 10519224. DOI: 10.2147/HMER.S326468.


Ganoderic acids-rich ethanol extract from protects against alcoholic liver injury and modulates intestinal microbiota in mice with excessive alcohol intake.

Guo W, Cao Y, You S, Wu Q, Zhang F, Han J Curr Res Food Sci. 2022; 5:515-530.

PMID: 35281335 PMC: 8913248. DOI: 10.1016/j.crfs.2022.02.013.


Elevated blood monocyte counts in alcohol-associated hepatitis.

Voss J, Li Z, Weinman S JGH Open. 2022; 6(2):148-151.

PMID: 35155825 PMC: 8829102. DOI: 10.1002/jgh3.12707.

References
1.
Sacco R, Romano A, Mazzoni A, Bertini M, Federici G, Metrangolo S . Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study. J Crohns Colitis. 2013; 7(12):e692-7. DOI: 10.1016/j.crohns.2013.06.012. View

2.
Horie Y, Yamagishi Y, Ebinuma H, Hibi T . Therapeutic strategies for severe alcoholic hepatitis. Clin Res Hepatol Gastroenterol. 2011; 35(11):738-44. DOI: 10.1016/j.clinre.2011.07.005. View

3.
Thurman R . II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol. 1998; 275(4):G605-11. DOI: 10.1152/ajpgi.1998.275.4.G605. View

4.
Kamimura K, Imai M, Sakamaki A, Mori S, Kobayashi M, Mizuno K . Granulocytapheresis for the treatment of severe alcoholic hepatitis: a case series and literature review. Dig Dis Sci. 2013; 59(2):482-8. DOI: 10.1007/s10620-013-2871-y. View

5.
Thursz M, Richardson P, Allison M, Austin A, Bowers M, Day C . Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015; 372(17):1619-28. DOI: 10.1056/NEJMoa1412278. View